Drugmaker Moves To Stop Natal Vitamin Reclassification
A drugmaker hit a pharmaceutical information provider with a lawsuit in California federal court on Thursday, alleging that its upcoming decision to designate prenatal vitamins as nonprescription is a deceptive change...To view the full article, register now.
Already a subscriber? Click here to view full article